Such a switch echoes recent findings that high-grade gliomas suppress broad endocytic machinery: a proteomics study reported large-scale depletion of clathrin, AP-2, dynamins and related factors in glioma, leading to sustained receptor signaling [34]. The gene discussed is DNM1; the disease is central nervous system cancer.